Kazakhstan Implements Ban on E-Cigarettes and Vaping Products

Regulations by 2FIRSTS.ai
Jun.20.2024
Kazakhstan Implements Ban on E-Cigarettes and Vaping Products
Kazakhstan officially bans sales, distribution, and import of e-cigarette products, with severe penalties for violations, effective today.

According to Tengrinews.kz, on June 20th, Kazakhstan officially implemented a new regulation today that aims to prohibit the sale, distribution, and import of e-cigarette products.

 

According to the recently passed Health Issues Amendment Act, popular e-cigarettes or disposable e-cigarettes are now banned in Kazakhstan. Although using e-cigarettes will not be penalized, selling, promoting, and importing these products will be subject to criminal liability.

 

According to the revised clauses in the Health Law, adjustments have also been made in the Criminal Law. Now, a new Article 301-1 has been added to the law, governing the circulation of non-tobacco products, electronic consumption systems (e-cigarettes), spices, and their e-liquids. Part 1 sets forth penalties for the sale and dissemination of e-cigarettes: fines of up to 200 MRP (738,400 junko or $1602.67 USD in 2024), or up to 200 hours of community service, or up to 50 days of detention. Part 2 stipulates penalties for the import and production of e-cigarettes: fines of up to 2000 MRP (730,000 junko or $15,844 USD in 2024), or up to 600 hours of community service, or up to 2 years of restriction or deprivation of liberty.

 

If these actions are repeatedly carried out by criminal groups and involve particularly large amounts of income, the penalties will be more severe: fines up to 5000 MRP (equivalent to 1.84 million Jankos in 2024 [39,936 US dollars]), or up to 1200 hours of community service, or a maximum of 5 years of restriction/deprivation of freedom.

 

In response to an official inquiry from Tengrinews.kz, the Ministry of Internal Affairs of Kazakhstan stated:

 

The act of distributing e-cigarettes should be understood as passing on e-cigarettes to others. This behavior will lead to criminal liability, regardless of its form, and regardless of whether there is any material or other benefits.

 

Smoking e-cigarettes in inappropriate places will result in the same penalties as smoking traditional cigarettes— a fine of 3 MRP (11,076 kongos [24.04 USD]) in 2024.

 

In addition, the amendment introduced a precise definition of e-cigarettes in the "People's Health and Hygiene System Code.

 

Electronic consumer systems (e-cigarettes) flavorings; electronic consumer systems (e-cigarettes) and their liquids; non-smoking tobacco products; products imitating tobacco products. Previously, on April 19th, President of Kazakhstan Kassym-Jomart Tokayev signed the "Law amending and supplementing certain laws and regulations regarding health issues in the Republic of Kazakhstan".

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
Sweden on Track to Become Europe’s First Smoke-Free Nation as Snus and Nicotine Pouches Support Declining Smoking Rates
Sweden on Track to Become Europe’s First Smoke-Free Nation as Snus and Nicotine Pouches Support Declining Smoking Rates
According to Gulf News, Sweden is nearing the World Health Organization’s smoke-free threshold, with daily smoking falling below 5%. Two decades of public health efforts and the growing use of lower-risk alternatives such as Snus and tobacco-free nicotine pouches have contributed to this shift, alongside declines in tobacco-related deaths and lung cancer cases.
Dec.04 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Hanwha Securities: KT&G's Global Market Share Expected to Hit New High, Overseas Heated Tobacco Sales Projected to Grow 74%
Hanwha Securities: KT&G's Global Market Share Expected to Hit New High, Overseas Heated Tobacco Sales Projected to Grow 74%
KT&G predicted to reach all-time high global market share in 2025, with Q3 sales expected to surge 10%.
Oct.16 by 2FIRSTS.ai
1,200 Health Leaders Urge UK Parliament to Pass Tobacco and Vapes Bill Swiftly
1,200 Health Leaders Urge UK Parliament to Pass Tobacco and Vapes Bill Swiftly
Over 1,200 UK health leaders urged Parliament to pass the Tobacco and Vapes Bill quickly, calling it vital to protect future generations. The bill would ban tobacco sales to anyone born after Jan 1, 2009, and restrict vape packaging and flavours. Health groups warned delays risk undermining “gamechanging” public health reforms.
Oct.27 by 2FIRSTS.ai
Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia
Product | FLONQ Parent Company Launches New Vaping Brand ROQY: Two Hybrid-Nicotine Devices Debut in Russia
Alfabet Labs, the parent company of FLONQ, has recently launched its new vaping brand ROQY in Russia, debuting two products: ROQY L and ROQY M. Both devices use a hybrid nicotine formulation combining nicotine salts and freebase nicotine and are each available in 19 flavors. The two products are now on sale via the official ROQY website as well as multiple online and offline retailers across Russia.
Nov.19 by 2FIRSTS.ai